Thai Court Reinstates Pro-Compulsory Licensing Board
This article was originally published in PharmAsia News
Thailand's Administrative Court ordered reinstated six members of the Government Pharmaceutical Organisation who advocated the country's controversial compulsory-licensing policy. Among the six was the former GPO chairman, Vichai Chokewiwat, who had been sacked by the Public Health Minister Chaiya Sasomsab. Chaiya, a strong opponent of the compulsory-licensing policy for major drugs, fired the six on grounds of declining profits. Vichai said he would arrange an early meeting of the old board, with its first move to speed up the import of generic versions of Sanofi-Aventis' oncologic Taxotere (docetaxel), one of the drugs on Thailand's compulsory licensing list. (Click here for more
You may also be interested in...
Sanofi has named the head of its new API business; Sweden's Enzymatica has hired talent from J&J and L'Oreal; and Bayer has a new transformation officer.
The Global Self-Care Federation is looking to consolidate the shift towards self-care seen during the pandemic by promoting trust, innovation and growth in policy. An upcoming webinar hosted by the GSCF will also explore the theme of "Advancing Trust in the Self-Care Industry."
After seeing a spike in demand due to the coronavirus pandemic in Q1, with a corresponding dip in Q2, the generics industry has largely seen single-digit drops in net revenues in the third quarter of 2020. Meanwhile, the Indian pharma market has seen recovery after facing a challenging coronavirus-induced slump in the first two quarters of 2020.